![Qing Sarah Yuan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Qing Sarah Yuan
Directeur Technique/Scientifique/R&D chez
SIGILON THERAPEUTICS, INC.
Profil
Qing Sarah Yuan is Chief Technical Operations Officer at Sigilon Therapeutics, Inc. since 2022 and Chief Technology Officer at Cabaletta Bio, Inc. since 2024.
Former roles include Head-Technical Development at Bioverativ, Inc. from 2017 to 2019 and Vice President-Process & Analytical Development at 2seventy Bio, Inc. Education includes a doctorate from the University of Wisconsin and an undergraduate degree from the University of California, Berkeley.
Postes actifs de Qing Sarah Yuan
| Sociétés | Poste | Début |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 07/03/2022 |
| CABALETTA BIO, INC. | Directeur Technique/Scientifique/R&D | 01/06/2024 |
Anciens postes connus de Qing Sarah Yuan
| Sociétés | Poste | Fin |
|---|---|---|
| BIOVERATIV INC | Corporate Officer/Principal | 01/01/2019 |
| 2SEVENTY BIO, INC. | Corporate Officer/Principal | - |
Formation de Qing Sarah Yuan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in discovery, research, development and commercialization of therapies for hemophilia & blood disorders | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
Cabaletta Bio, Inc.
 Cabaletta Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which discovers and develops engineered cell therapies for B cell-mediated autoimmune diseases | Health Technology |
2seventy Bio, Inc.
 2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology, immunology and cardiovascular pharmaceuticals products | Health Technology |
